Advances in Cancer Immunotherapy™

Specifically designed for clinical oncologists and the entire unit of care involved in treating cancer patients with immunotherapy, these introductory, CME-certified programs will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of 1) the underlying principles of tumor immunology and immunotherapy, 2) the clinical indications for cancer immunotherapy and appropriate selection of patients, 3) patient management, and 4) the therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.

Attendees can also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.
+ show speakers and program
Program Schedule

(as of July 18, 2014)

Presentations include allotted time for Audience Response System (ARS) assisted audience interaction as well as general question and answer time.

8:00 am - 8:10 am Welcome and Overview

Session I: Basic Principles of Tumor Immunology and Immunotherapy
2.25 AMA PRA Category 1 Credits™

8:10 am - 8:50 am Immunology 101, Speaker: Stephen P. Shoenberger, PhD – La Jolla Institute for Asthma and Immunology
8:50 am - 9:20 am Inflammation and Tumor Development
9:20 am - 9:50 am Immune Changes Associated with Tumor Growth and Regression, Speaker: Jack D. Bui, MD, PhD – University of California, San Diego
9:50 am - 10:20 am Panel Discussion
10:20 am - 10:35 am Break

Session II: Targeting the Tumor
2 AMA PRA Category 1 Credits™

10:35 am - 11:05 am Current State of Immune Checkpoint Inhibitors, Speaker: Omid Hamid, MD – The Angeles Clinic and Research Institute
11:05 am - 11:35 am Oncolytic Virus Therapy in Cancer Immunotherapy, Speaker: Robert Hans Ingemar Andtbacka, MD, CM, FACS, FRCSC – University of Utah
11:35 am - 12:05 pm Cell Therapy, Speaker: Mark Faries, MD – The John Wayne Cancer Institute
12:05 pm - 12:35 pm Panel Discussion and Case Studies
12:35 pm - 1:20 pm Lunch

Session III: New Combination Strategies: When More is Better and Less May be More
2.25 AMA PRA Category 1 Credits™

1:20 pm - 1:50 pm Combination Therapy, Speaker: Bartosz Chmielowski, MD, PhD – UCLA
1:50 pm - 2:20 pm Radiation and Immune Therapy, Speaker: Brendan D. Curti, MD – Earle A. Chiles Research Institute, Providence Cancer Center
2:20 pm - 2:50 pm Biomarkers: How to Select the Correct Patient for Which Therapy, Speaker: Gregory A. Daniels, MD, PhD – University of California San Diego Cancer Center
2:50 pm - 3:20 pm Panel Discussion and Case Studies
3:20 pm - 3:30 pm Closing Remarks

22 Aug - 22 Aug 2014
San Diego
United States of America
meeting website